Te Ahumairangi 出售了 Quest Diagnostics 的股票，该公司的收益超出预期并提高了股息。 Te Ahumairangi sold shares in Quest Diagnostics, which beat earnings estimates and raised its dividend.

泰阿穆阿里安投资管理有限公司通过出售6810股股票减少了其在Quest诊断的股份, Te Ahumairangi Investment Management Ltd has reduced its stake in Quest Diagnostics by selling 6,810 shares, leaving it with 43,194 shares valued at $6.52 million. Quest Diagnostics 报告称，最近一个季度的每股收益为 2.23 美元，超出预期。 Quest Diagnostics reported $2.23 earnings per share for the latest quarter, beating estimates. 该公司的股利收益为1.89%,最近宣布每季度每股0.80美元的股利。 The company has a dividend yield of 1.89% and recently announced a quarterly dividend of $0.80 per share. 分析师给科斯特诊断公司一个"中等购买"评级, 目标价178.38美元. Analysts have given Quest Diagnostics a "Moderate Buy" rating with a target price of $178.38.